[Xalacom: possibilities and advantages of the drug in the treatment of patients with glaucoma]. / Ksalakom: vozmozhnosti i preimushchestva preparata v terapii glaukomy.
Vestn Oftalmol
; 138(5): 119-125, 2022.
Article
em Ru
| MEDLINE
| ID: mdl-36288426
ABSTRACT
The strategy of glaucoma therapy is aimed at preserving visual functions and ensuring an acceptable quality of life for patients. To achieve this strategic goal, clinicians in their practice use drugs that affect the main factor in the progression of the disease - intraocular pressure (IOP), aiming to reduce it to an individual target level. It is not always possible to achieve optimal IOP values with monotherapy. Many patients require a combination of drugs from different pharmacological groups. Xalacom is a fixed drug with good tolerability and t hypotensive effect. This review focuses on the benefits of this drug for the treatment of glaucoma.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Prostaglandinas F Sintéticas
/
Glaucoma
/
Hipertensão Ocular
Aspecto:
Patient_preference
Limite:
Humans
Idioma:
Ru
Revista:
Vestn Oftalmol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Federação Russa